Abstract
This is an oversimplification of the myriad of molecular functions under the control of these genes. Proto-oncogenes,as we discussed in the last chapter, encode for proteins in the cell signaling pathway and apoptosis. When mutated into oncogenes, their function results in an unregulated stimulation of cell division. Mutated oncogenes act in a dominant genetic mode, producing an abnormal phenotype, even though a second allele of the gene is not mutated. Tumor suppressor genes (at one time called antioncogenes) have the normal physiologic role of retarding cell division. Tumor suppressor genes differ from oncogenes in several other ways besides their opposing effects on cell division. Tumor suppressor genes do not exist in a viral form, as is the case for oncogenes. This should not be surprising. A retrovirus benefits from carrying an oncogene along in its genome to promote division in cells it infects. There would be no benefit to a virus in carrying a copy of a tumor suppressor gene to retard cell division. Tumor suppressor genes work with the DNA repair system, so necessary in maintaining the stability of the genome. Tumor suppressor genes in mutated form can be passed on as germline heritable DNA defects. They are the cause of the syndromes of genetic predisposition to cancer. However, tumor suppressor gene mutations occur more commonly as sporadic somatic cell mutations in nonfamilial cancers. Tumor suppressor genes are recessive. Both copies of the gene must be mutated to produce the phenotype: failure to inhibit growth of damaged cells. Table 4.1 lists these contrasting features of oncogenes and tumor suppressor genes.
Article Footnote
“Oncogenes promote cell growth; tumor suppressor genes inhibit it.”
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Begley S. The cancer killer. Newsweek, Dec 23, 1996: 42–47.
Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science. 1997;278:1043–1050.
Fearon ER, Vogelstein B. Tumor suppressor and DNA repair gene defects in human cancer. In: Holland JF, Bast RC, Morton DL, Frei E, Kufe DW, Weichselbaum RR, eds. Cancer Medicine. 4th ed. Baltimore: Williams and Wilkins; 1997:97–117.
Tumor Protein p53; TP53. http://www.ncbi.nlm.nih.gov/cgi-bin/SCIENCE96/gene?TP53.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Ross, D.W. (1998). Tumor Suppressor Genes. In: Introduction to Oncogenes and Molecular Cancer Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1662-9_4
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1662-9_4
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-98392-9
Online ISBN: 978-1-4612-1662-9
eBook Packages: Springer Book Archive